BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BCRX is expected to report earnings to fall ∞% to -3 cents per share on July 31

BioCryst Pharmaceuticals BCRX Stock Earnings Reports

Q2'25

Est.

$-0.04

Q1'25

Beat

by $0.07

Q4'24

Missed

by $0.06

Q3'24

Est.

$-0.07

Q2'24

Beat

by $0.11

The last earnings report on May 05 showed earnings per share of 0 cents, beating the estimate of -7 cents. With 78.66K shares outstanding, the current market capitalization sits at 2.06B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+30%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

BCRX